CID 16131450

[3-[[5-(2-amino-6-oxo-1h-purin-9-yl)-3-[[5-(2-amino-6-oxo-1h-purin-9-yl)-3-[[5-(2-amino-6-oxo-1h-purin-9-yl)-3-[[3-[[5-(2-amino-6-oxo-1h-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl [10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] hydrogen phosphate

Structural Information

Molecular Formula
C87H119N27O37P6
SMILES
CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)OC3CCC4(C5CCC6(C(C5CC=C4C3)CCC6C(C)CCCC(C)C)C)C)OP(=O)(O)OCC7C(CC(O7)N8C=NC9=C8N=C(NC9=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)O
InChI
InChI=1S/C87H119N27O37P6/c1-38(2)8-7-9-39(3)44-12-13-45-43-11-10-41-18-42(14-16-86(41,5)46(43)15-17-87(44,45)6)146-152(122,123)135-27-54-48(20-60(141-54)109-25-40(4)76(116)108-85(109)121)147-154(126,127)137-29-56-50(22-62(143-56)112-35-97-67-73(112)101-82(90)105-78(67)118)150-156(130,131)139-31-58-52(24-64(145-58)114-37-99-69-75(114)103-84(92)107-80(69)120)151-157(132,133)138-30-57-51(23-63(144-57)113-36-98-68-74(113)102-83(91)106-79(68)119)149-155(128,129)136-28-55-49(21-61(142-55)110-33-95-65-70(88)93-32-94-71(65)110)148-153(124,125)134-26-53-47(115)19-59(140-53)111-34-96-66-72(111)100-81(89)104-77(66)117/h10,25,32-39,42-64,115H,7-9,11-24,26-31H2,1-6H3,(H,122,123)(H,124,125)(H,126,127)(H,128,129)(H,130,131)(H,132,133)(H2,88,93,94)(H,108,116,121)(H3,89,100,104,117)(H3,90,101,105,118)(H3,91,102,106,119)(H3,92,103,107,120)
InChIKey
WEPXOPKIZSKAGH-UHFFFAOYSA-N
Compound name
[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl [10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen phosphate
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

2319.6687 Da
Monoisotopic Mass

-4.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 2320.6760 250.2
[M+Na]+ 2342.6579 259.6
[M-H]- 2318.6614 249.6
[M+NH4]+ 2337.7025 253.2
[M+K]+ 2358.6319 256.9
[M+H-H2O]+ 2302.6660 248.8
[M+HCOO]- 2364.6669 253.9
[M+CH3COO]- 2378.6826 255.4
[M+Na-2H]- 2340.6434 258.6
[M]+ 2319.6682 256.6
[M]- 2319.6692 256.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.